- Tytuł :
-
Urology in 2020. PARP inhibitors make clinical splash as COVID-19's impact is felt throughout specialty. (cover story) - Autorzy :
- Temat :
-
THERAPEUTIC use of monoclonal antibodies
BLADDER tumors
ENZYME inhibitors
METASTASIS
BIOLOGICAL mutation
PROSTATE tumors
UNITED States. Food & Drug AdministrationUROLOGY
DRUG approval
OVERACTIVE bladder
COVID-19 pandemic - Źródło :
-
Urology Times. Dec2020, Vol. 48 Issue 12, p1-18. 4p. -
Periodyk